ASSESSING THE IMPACT OF THYROID HORMONE IMBALANCE ON CARDIOVASCULAR HEALTH IN AGING POPULATIONS
Main Article Content
Keywords
Thyroid Hormone, Cardiovascular Health, Aging, Hyperthyroidism, Hypothyroidism
Abstract
Introduction: Thyroid hormones like T4 and T3 are hormones synthesized in the thyroid gland and are involved in metabolism, growth, and differentiation. It was also found that in aging people, the effects of thyroid hormone dysfunction in heart disease are aggravated. disease.
Objective: to investigate the effect of thyroid hormones dysregulation on cardiovascular disease in those who are 60 years of age and above.
Methodology: This cross-sectional study was conducted at Khyber Teaching Hospital, Peshawar, from January 2021 to January 2022 with a sample size of 85 participants, who were divided into two groups: hypothyroidism (n=51) and hyperthyroidism (n=34). Participants aged 60 years and older with confirmed thyroid hormone imbalances were included, while those with severe chronic illnesses affecting cardiovascular outcomes were excluded. Data were retrieved from hospital electronic medical records, encompassing demographic details, clinical characteristics, and cardiovascular health outcomes such as age, sex, BMI, duration of thyroid disorder, presence of hypertension and diabetes, ECG and echocardiogram results, LDL cholesterol levels, and incidence of atrial fibrillation
Results: The results indicated that the hypothyroid group had a significantly longer duration of thyroid disorder compared to the hyperthyroid group (7.3 ± 2.9 years vs. 5.4 ± 3.4 years, p=0.023). Hypothyroid patients also showed a higher prevalence of ECG abnormalities (68.2% vs. 31.7%, p=0.05) and elevated LDL cholesterol levels (>130 mg/dL) (38.8% vs. 28.2%, p=0.021). However, there were no significant differences in age, sex distribution, BMI, or the incidence of hypertension, diabetes, echocardiogram abnormalities, or atrial fibrillation between the groups. These findings underscore the considerable impact of hypothyroidism on cardiovascular health compared to hyperthyroidism in older adults.
Conclusion: Thyroid hormone dysfunctions play some role in initiating cardiovascular diseases in the aging population. Thus, according to the differences in cardiovascular outcomes in patients with hypothyroid and hyperthyroidism, the necessity of TSH measurement and individualized approach to CVD risk management in elderly patients with thyroid diseases is emphasized. These results should apply at the patient care level and provide guidance for future investigations of thyroid diseases and their cardiovascular consequences in geriatric patients.
References
2. Al-Suhaimi EA, Khan FA. Thyroid glands: Physiology and structure. Emerging concepts in endocrine structure and functions: Springer; 2022. p. 133-60.
3. Pandya N, Hames E. Thyroid Disorders in Older Adults. Geriatric Medicine: A Person Centered Evidence Based Approach: Springer; 2024. p. 475-94.
4. Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016;26(10):1343-421.
5. Teixeira PdFdS, Dos Santos PB, Pazos-Moura CC. The role of thyroid hormone in metabolism and metabolic syndrome. Therapeutic advances in endocrinology and metabolism. 2020;11:2042018820917869.
6. Galton VA, Hernandez A. Thyroid hormone metabolism: a historical perspective. Thyroid. 2023;33(1):24-31.
7. Khan R, Sikanderkhel S, Gui J, Adeniyi A-R, O’Dell K, Erickson M, et al. Thyroid and cardiovascular disease: a focused review on the impact of hyperthyroidism in heart failure. Cardiology research. 2020;11(2):68.
8. Paschou SA, Bletsa E, Stampouloglou PK, Tsigkou V, Valatsou A, Stefanaki K, et al. Thyroid disorders and cardiovascular manifestations: an update. Endocrine. 2022;75(3):672-83.
9. Corona G, Croce L, Sparano C, Petrone L, Sforza A, Maggi M, et al. Thyroid and heart, a clinically relevant relationship. Journal of Endocrinological Investigation. 2021;44(12):2535-44.
10. Abdel-Moneim A, Gaber AM, Gouda S, Osama A, Othman SI, Allam G. Relationship of thyroid dysfunction with cardiovascular diseases: updated review on heart failure progression. Hormones. 2020;19(3):301-9.
11. Yamakawa H, Kato TS, Noh JY, Yuasa S, Kawamura A, Fukuda K, et al. Thyroid hormone plays an important role in cardiac function: from bench to bedside. Frontiers in physiology. 2021;12:606931.
12. Arcos MLB. Role of thyroid hormones-induced oxidative stress on cardiovascular physiology. Biochimica et Biophysica Acta (BBA)-General Subjects. 2022;1866(12):130239.
13. Chaulin AM, Grigorieva JV, Suvorova GN, Duplyakov DV. Experimental modeling of hypothyroidism: principles, methods, several advanced research directions in cardiology. Russian Open Medical Journal. 2021;10(3):311.
14. Su X, Peng H, Chen X, Wu X, Wang B. Hyperlipidemia and hypothyroidism. Clinica Chimica Acta. 2022;527:61-70.
15. Olanrewaju OA, Asghar R, Makwana S, Yahya M, Kumar N, Khawar MH, et al. Thyroid and Its Ripple Effect: Impact on Cardiac Structure, Function, and Outcomes. Cureus. 2024;16(1).
16. Ibraheem A, Abdullah A. Thyrotoxic Cardiomyopathy Unveiled: Insights From a Compelling Case Report. Cureus. 2023;15(12).
17. Sabatino L, Ndreu R, Vassalle C. Oxidative stress and heart disease: the thyroid hormone mediation. Vessel Plus. 2021;5:3.
18. Gauthier BR, Sola‐García A, Cáliz‐Molina MÁ, Lorenzo PI, Cobo‐Vuilleumier N, Capilla‐González V, et al. Thyroid hormones in diabetes, cancer, and aging. Aging cell. 2020;19(11):e13260.
19. Liu Y, Shan Z, Society EMDGotCG, Thyroid Group of the Chinese Society of Endocrinology CMA, Cheng M, Cao CX, et al. Expert consensus on diagnosis and treatment for elderly with thyroid diseases in China (2021). Aging Medicine. 2021;4(2):70-92.
20. William A. Medical Medium Thyroid Healing: The Truth Behind Hashimoto's, Graves', Insomnia, Hypothyroidism, Thyroid Nodules & Epstein-Barr: Hay House, Inc; 2021.
21. von Hafe M, Neves JS, Vale C, Borges-Canha M, Leite-Moreira A. The impact of thyroid hormone dysfunction on ischemic heart disease. Endocrine connections. 2019;8(5):R76-R90.
22. Berta E, Lengyel I, Halmi S, Zrínyi M, Erdei A, Harangi M, et al. Hypertension in thyroid disorders. Frontiers in endocrinology. 2019;10:482.
23. Birck MG, Almeida-Pititto Bd, Janovsky CC, Goulart AC, Santos IS, Teixeira PdFdS, et al. Thyroid-stimulating hormone and thyroid hormones and incidence of diabetes: prospective results of the Brazilian longitudinal study of adult health (ELSA-BRASIL). Thyroid. 2022;32(6):694-704.
24. Kalra S, Aggarwal S, Khandelwal D. Thyroid dysfunction and dysmetabolic syndrome: the need for enhanced thyrovigilance strategies. International journal of endocrinology. 2021;2021 (1):9641846.
25. Feldt-Rasmussen U, Effraimidis G, Bliddal S, Klose M. Consequences of undertreatment of hypothyroidism. Endocrine. 2024;84(2):301-8.
26. Jabbar A, Pingitore A, Pearce SH, Zaman A, Iervasi G, Razvi S. Thyroid hormones and cardiovascular disease. Nature Reviews Cardiology. 2017;14(1):39-55.
27. Gluvic ZM, Zafirovic SS, Obradovic MM, Sudar-Milovanovic EM, Rizzo M, Isenovic ER. Hypothyroidism and risk of cardiovascular disease. Current Pharmaceutical Design. 2022;28(25):2065-72.
28. Gluvic Z, Obradovic M, Stewart AJ, Essack M, Pitt SJ, Samardzic V, et al. Levothyroxine treatment and the risk of cardiac arrhythmias–focus on the patient submitted to thyroid surgery. Frontiers in endocrinology. 2021;12:758043.
29. Ahmadi N, Ahmadi F, Sadiqi M, Ziemnicka K, Minczykowski A. Thyroid gland dysfunction and its effect on the cardiovascular system: a comprehensive review of the literature. Endokrynologia Polska. 2020;71(5):466-78.
30. Liu H, Peng D. Update on dyslipidemia in hypothyroidism: the mechanism of dyslipidemia in hypothyroidism. Endocrine Connections. 2022;11(2).
31. Bekiaridou A, Kartas A, Moysidis DV, Papazoglou AS, Baroutidou A, Papanastasiou A, et al. The bidirectional relationship of thyroid disease and atrial fibrillation: Established knowledge and future considerations. Reviews in Endocrine and Metabolic Disorders. 2022;23(3):621-30.
32. Biondi B, Cappola AR. Subclinical hypothyroidism in older individuals. The Lancet Diabetes & Endocrinology. 2022;10(2):129-41.